Congenital nephrotic syndrome associated with congenital toxoplasmosis.
D000936:Antigen-Antibody Complex / Q000032:analysis; D001798:Blood Proteins / Q000032:analysis; D002784:Cholesterol / Q000097:blood; D004487:Edema / Q000209:etiology; D005455:Fluorescent Antibody Technique; D005665:Furosemide / Q000627:therapeutic use; D006801:Humans; D007070:Immunoglobulin A / Q000032:analysis; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D007223:Infant; D007678:Kidney Glomerulus / Q000276:immunology; D008297:Male; D008854:Microscopy, Electron; D009404:Nephrotic Syndrome / Q000151:congenital* / Q000188:drug therapy / Q000276:immunology; D011241:Prednisone / Q000627:therapeutic use; D011507:Proteinuria / Q000209:etiology; D011739:Pyrimethamine / Q000627:therapeutic use; D013411:Sulfadiazine / Q000627:therapeutic use; D014125:Toxoplasmosis, Congenital / Q000150:complications* / Q000188:drug therapy / Q000276:immunology
D000936:Antigen-Antibody Complex; D001798:Blood Proteins; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D013411:Sulfadiazine; D005665:Furosemide; D002784:Cholesterol; D011241:Prednisone; D011739:Pyrimethamine